Abstract
Objective: To analyze the relationship between neurological symptoms and treatment outcomes of anti-NMDA receptor encephalitis at the Neurology Center of Bach Mai Hospital.
Subjects: We selected 50 who were diagnosed with encephalitis at Bach Mai Hospital from January 1st, 2020, to October 31st, 2023.
Methods: Cross-sectional descriptive study.
Results:
Among the 50 patients studied, 48% achieved good treatment outcomes, while 52% had poor outcomes. There was evidence of a significant difference in treatment outcomes between the group with symptoms such as consciousness disorders, dyskinesia and movement disorders, speech disorders, and dysautonomia compared to the group without these symptoms (p<0.05). There was no significant difference in treatment outcomes between the group with symptoms such as seizures, memory impairment, and sleep disorders compared to the group without these symptoms (p>0.05).
Conclusion: In our study, 48% of patients achieved good treatment outcomes at discharge. Symptoms of consciousness disorders, dyskinesia and movement disorders, speech disorders, and dysautonomia were associated with treatment outcomes.
